Lisa Ricciardi, President and CEO of Cognition Therapeutics, was recently a guest on Benzinga's All-Access. Cognition ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...

What’s exciting is that medications that block CXCR3 are already being tested for other health problems, like arthritis. If ...

New research provides further evidence that getting uncontrolled high blood pressure under control could be one way to reduce ...

Reducing high blood pressure substantially lowers the risk of dementia and cognitive impairment without dementia, according ...

Agitation is a symptom in many types of dementia that makes patients distressed, restless, and aggressive. Learn about agitation in dementia here.

Pseudodementia had sometimes been linked to any factitious mental illness, however, in the 1960s the term came to be known ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

Memory loss is a potential sign of dementia that occurs in progressive stages. Learn about treating and preventing dementia ...

Imagine discovering that up to one in three dementia cases could be prevented with something as simple as treating hearing ...

Lowering high blood pressure reduces dementia risk by 15%, as shown in a clinical trial involving 34,000 patients in China.